Loading
Boston Medical Sciences
Boston Medical Sciences is the developer of a non-invasive colorectal cancer detection platform designed to improve patient outcomes by leveraging data for decision-making. The company's platform utilizes artificial intelligence to perform virtual bowel cleansing, which helps prepare the colon for examination without the traditional discomfort associated with laxatives, enabling healthcare providers with enhanced detection and treatment through technology.
Funding
Every round, secondary, debt facility or acquisition involving Boston Medical Sciences that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—